Global Electroceutical Devices Market Growth 2016 Share, Trend, Segmentation and Forecast to 2020

Micro-Hybrid Vehicle -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021

PUNE, INDIA, August 16, 2016 /EINPresswire.com/ -- Electroceutical Devices Industry

Description

Wiseguyreports.Com Adds “Micro-Hybrid Vehicle -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021” To Its Research Database

The electroceuticals technology utilizes devices that bring about a change in the nervous system by modulating brain activity. The treatment delivered by neurostimulation devices brings about life changing transformation in patients who fail to respond to traditional approaches. The opportunities to development new therapies for a wide variety of neurological and psychological conditions are attracting a lot of companies, startups and investments. According to IQ4I analysis, the global electroceutical devices market is expected to grow at a double digit CAGR from 2015 to 2022. Factors driving the electroceutical devices market include, projected increase in patients with chronic pain, neurological diseases, psychiatric conditions, cardiology conditions, improvements in technology such as miniaturization, better battery technology, wearable, wireless micro-current stimulation are all contributing to growth of electroceutical devices market whereas shocking areas of neural tissue to stimulate the desired response, electrical devices have been clunky and imprecise, mode of action is not known so basically it is a trial and error method etc are the factors hampering the market growth. Advancement of technology with its wide application areas shows that electroceutical devices market has vast opportunities in the coming years.

Report Detail’s@ https://www.wiseguyreports.com/reports/605490-electroceutical-devices-global-market-forecast-to-2022


Electroceutical devices market is segmented on the basis of technology as internal and external electroceutical devices. The internal electroceutical devices is classified into

Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Pacemakers, Implantable Cardioverter Defibrillator (ICD), Cochlear Implants and Others with Gastric Electrical Stimulation (GES) and Respiratory Electrical Stimulation (RES)/Phrenic Nerve Stimulation (PNS). The external electroceutical devices are classified as Transcutaneous External Nerve Stimulation (TENS), External Pacemakers, External Defibrillators and Others (Tumour Treating Fields (TTF), Micro-current stimulation).

Based on the application the electroceutical devices market is segmented into Pain management,

Central Nervous System (CNS), Gastroenterology/Urology, Hearing aids, Cardiology and other applications. Based on end-users the market is segmented into hospitals and home care.

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/605490-electroceutical-devices-global-market-forecast-to-2022

North America accounts for the highest market share followed by Europe. The steep rise in ageing population, advancement in technology, awareness of people and favorable government policies makes U.S. the leader of electroceutical devices market. However, Asian countries especially India and China are the fast growing regions with its growing demand for electroceutical devices.

Major players in Electroceuticals devices market include

Boston Scientific (U.S.), St. Jude Medical (U.S), St. Jude Medical (U.S.), Cogentix medical (U.S.), LivaNova (U.K.), Biotronik (Germany), NeuroMetrix (U.S.), Nevro Corporation (U.S.) etc.

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

• North America

• Europe

• Asia-Pacific

• Rest of the World (RoW)

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=605490



Table of Content

EXECUTIVE SUMMARY 28
2 INTRODUCTION 33
2.1 KEY TAKEAWAYS 33
2.2 REPORT DESCRIPTION 34
2.3 MARKETS COVERED 35
2.4 STAKEHOLDERS 37
2.5 RESEARCH METHODOLOGY 37
2.5.1 MARKET SIZE ESTIMATION 39
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION 41
2.5.3 SECONDARY SOURCES 42
2.5.4 PRIMARY SOURCES 42
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 43
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 44
2.5.7 ASSUMPTIONS 44
3 MARKET ANALYSIS 46
3.1 INTRODUCTION 46
3.2 MARKET SEGMENTATION 47
3.3 FACTORS INFLUENCING MARKET 49
3.3.1 DRIVERS AND OPPORTUNITIES 50
3.3.1.1 Emergence of electroceuticals as a standalone therapy 50
3.3.1.2 Increasing r & d investments for electroceuticals research 50
3.3.1.3 Increasing aging population prone to neurological diseases 51
3.3.1.4 Cost effective and can be withdrawn when adverse effect is seen 52
3.3.2 RESTRAINTS AND THREATS 53
3.3.2.1 Side effects and risks associated with the use 53
3.3.2.2 Availability of alternative treatments 53
3.3.2.3 Lack of trained professionals 54
3.4 REGULATORY AFFAIRS 54
3.4.1 U.S. 54
3.4.2 EUROPE 55
3.4.3 CHINA 56
3.4.4 CANADA 57
3.4.5 INDIA 57
3.5 REIMBURSEMENT SCENARIO 58
3.5.1 CPT CODES 60
3.6 PATENT ANALYSIS 81
3.7 TECHNOLOGICAL ADVANCEMENTS 83
3.7.1 INTRODUCTION 83
3.7.2 MINIATURIZATION 84
3.7.3 WIRELESS MICRO- CURRENT STIMULATION 85
3.7.4 WEARABLE PAIN MANAGEMENT TECHNOLOGY 86
3.7.5 MULTI-POINT PACING TECHNOLOGY 86
3.7.6 INTRANASAL TEAR NEUROSTIMULATOR 87
3.8 UPCOMING TECHNOLOGY AND PRODUCT LAUNCH 88
3.9 FUNDING SCENARIO 109
3.10 ELECTROCEUTICAL DEVICES - DEALS 111
3.11 CLINICAL TRIAL DATA 113
3.12 PORTER’S FIVE FORCE ANALYSIS 130
3.12.1 THREAT OF NEW ENTRANTS 132
3.12.2 THREAT OF SUBSTITUTES 132
3.12.3 BARGAINING POWER OF SUPPLIERS 133
3.12.4 BARGAINING POWER OF BUYERS 133
3.12.5 RIVALRY AMONG EXISTING COMPETITORS 134
3.13 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 135
4 ELECTROCEUTICAL DEVICES GLOBAL MARKET, BY TECHNOLOGY 138
4.1 INTRODUCTION 138
4.1.1 INTERNAL ELECTROCEUTICALS 141
4.1.1.1 Spinal Cord Stimulation (SCS) 146
4.1.1.2 Deep Brain Stimulation (DBS) 149
4.1.1.3 Vagus Nerve Stimulation (VNS) 152
4.1.1.4 Sacral Nerve Stimulation(SNS) 155
4.1.1.5 Internal pacemakers 158
4.1.1.6 Implantable Cardioverter Defibrillator (ICDS) 161
4.1.1.7 Electric Acoustic Stimulation(EAS) 164
4.1.1.8 Others 167
4.1.1.8.1 Gastric Electric Stimulation (GES) 170
4.1.1.8.2 Respiratory Electrical Stimulation (RES)/
Phrenic Nerve Stimulation 171
4.1.2 EXTERNAL ELECTROCEUTICALS 172
4.1.2.1 Transcutaneous Electrical Nerve Stimulation (TENS) 177
4.1.2.2 External pacemakers 180
4.1.2.3 External & wearable defibrillators 183
4.1.2.4 Others 186
4.1.2.4.1 Tumor Treating Fields(TTFIELDS) 189
4.1.2.4.2 Micro-Current Stimulation 190

Continued...

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK)

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here